BOEHRINGER INGELHEIM

We are a globally operating, independent corporation committed to researching, developing, manufacturing and marketing drugs for human and veterinary medicine. For more than 100 years, our goal has been to secure and maintain our independence by means of continuous growth.

The Boehringer Ingelheim Corporation, with 152 subsidiaries in 45 countries across the world and a total of around 34,000 employees, is one of the world's 20 leading pharmaceutical companies.With its activities focused on Human Pharmaceuticals and Animal Health, Boehringer Ingelheim posted net sales of almost 7.4 billion Euro in 2002.

A family-owned company founded in 1885 and headquartered in Ingelheim am Rhein, Boehringer Ingelheim can look back on a long history of successful pharmaceutical innovations and product launches.

In the business year 2003, Boehringer Ingelheim spent approximately 1.2 billion euro on research and development, more than one fifth of net sales in its largest business segment Prescription Medicines. The company's research and development activities and production and distribution centres are spread across the entire globe.

General Manager: David Scotcher

P.O. Box 3264
Dubai, UAE

Tel: 00971 4 3346159-208
Fax: 00971 4 3345751

Website: www.boehringer-ingelheim.com